ArticleJournal of gastrointestinal oncology2024
Development and nomogram prediction of early postoperative recurrence in hepatocellular carcinoma based on preoperative CT imaging radiomic features and serum features related to microvascular infiltration.
Article in Journal of gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A CECT-Based 2PI System as a Novel Noninvasive Prognostic Tool for Hepatocellular Carcinoma: A Dual-Validation Study.Cancer science · 2026Article
- The Roles and Clinical Significance of Major Hepatic-Derived Metabolites in Hepatocellular Carcinoma.Journal of gastroenterology and hepatology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hepatocellular carcinoma (HCC) is characterized by high postoperative recurrence rates, and predicting early recurrence is crucial for improving clinical outcomes, yet remains challenging. Both preoperative computed tomography (CT) imaging radiomic features and serum biomarkers related to microvascular infiltration are important indicators of HCC prognosis. This study aimed to develop a nomogram model incorporating both preoperative CT radiomic features and serum biomarkers associated with microvascular infiltration to predict early postoperative recurrence in HCC patients. Methods: The study included 156 HCC patients who underwent radical surgery at the Tumor Hospital Affiliated to Nantong University between January 2021 and January 2022. Preoperative CT imaging data were obtained for each patient, and radiomic features were extracted using the 3D Slicer software. Preoperative serum biomarkers related to microvascular invasion were collected, including alpha-fetoprotein (AFP), vascular endothelial growth factor A (VEGF-A), Speckled Protein 100 (SP100), and the Fibrosis-4 (FIB-4) index levels. Postoperative follow-up was conducted for 2 years, during which recurrence data were collected. The radiomics score was generated through dimensionality reduction and least absolute shrinkage and selection operator (LASSO) regression analysis. Univariate and logistic regression analyses were used to identify independent risk factors for early postoperative recurrence of HCC. The nomogram model was constructed using R language, and its predictive performance was evaluated using receiver operating characteristic curves, calibration curves, and decision curve analysis curves. Results: Among the 156 patients, 60 experienced early recurrence, while 96 did not. Feature reduction through LASSO regression identified 10 optimal features from the venous phase and 4 optimal features from the arterial phase, leading to the development of a radiomics score formula. The early recurrence group had significantly higher radiomics scores than the non-early recurrence group [-1.35 (-2.29, 1.21) Conclusions: The nomogram model based on preoperative serum biomarkers related to microvascular infiltration and CT radiomic features demonstrated high predictive performance for early postoperative recurrence of HCC. However, further studies, including external validation, are needed to establish the model's generalizability and clinical applicability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.